CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of acute & chronic disorders which require the use of suppository
3.4.1.2. Increase in the geriatric population
3.4.1.3. Increase in initiatives for awareness and education for use of suppositories
3.4.2. Restraints
3.4.2.1. Manufacturing complexities
3.4.2.2. Limited drug compatibility
3.4.3. Opportunities
3.4.3.1. Technological advancements in suppositories
CHAPTER 4: PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Rectal Suppositories
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Vaginal Suppositories
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Urethral Suppositories
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE
5.1. Overview
5.1.1. Market size and forecast
5.2. Fatty Bases
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Water Miscible Base
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.3.4. Water Miscible Base Pharmaceutical Suppositories Market by Type
5.4. Emulsifying Bases
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.4.4. Emulsifying Bases Pharmaceutical Suppositories Market by Type
CHAPTER 6: PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital Pharmacies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Retail Pharmacies
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Online Sales
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals and Clinics
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Home Care
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Nursing Home
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE
8.1. Overview
8.1.1. Market size and forecast
8.2. OTC
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by region
8.2.3. Market share analysis by country
8.3. Prescribed Suppositories
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by region
8.3.3. Market share analysis by country
CHAPTER 9: PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast By Region
9.2. North America
9.2.1. Key market trends, growth factors and opportunities
9.2.2. Market size and forecast, by Type
9.2.3. Market size and forecast, by Base
9.2.4. Market size and forecast, by Distribution Channel
9.2.5. Market size and forecast, by End User
9.2.6. Market size and forecast, by Prescription Type
9.2.7. Market size and forecast, by country
9.2.7.1. U.S.
9.2.7.1.1. Market size and forecast, by Type
9.2.7.1.2. Market size and forecast, by Base
9.2.7.1.3. Market size and forecast, by Distribution Channel
9.2.7.1.4. Market size and forecast, by End User
9.2.7.1.5. Market size and forecast, by Prescription Type
9.2.7.2. Canada
9.2.7.2.1. Market size and forecast, by Type
9.2.7.2.2. Market size and forecast, by Base
9.2.7.2.3. Market size and forecast, by Distribution Channel
9.2.7.2.4. Market size and forecast, by End User
9.2.7.2.5. Market size and forecast, by Prescription Type
9.2.7.3. Mexico
9.2.7.3.1. Market size and forecast, by Type
9.2.7.3.2. Market size and forecast, by Base
9.2.7.3.3. Market size and forecast, by Distribution Channel
9.2.7.3.4. Market size and forecast, by End User
9.2.7.3.5. Market size and forecast, by Prescription Type
9.3. Europe
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Market size and forecast, by Type
9.3.3. Market size and forecast, by Base
9.3.4. Market size and forecast, by Distribution Channel
9.3.5. Market size and forecast, by End User
9.3.6. Market size and forecast, by Prescription Type
9.3.7. Market size and forecast, by country
9.3.7.1. Germany
9.3.7.1.1. Market size and forecast, by Type
9.3.7.1.2. Market size and forecast, by Base
9.3.7.1.3. Market size and forecast, by Distribution Channel
9.3.7.1.4. Market size and forecast, by End User
9.3.7.1.5. Market size and forecast, by Prescription Type
9.3.7.2. France
9.3.7.2.1. Market size and forecast, by Type
9.3.7.2.2. Market size and forecast, by Base
9.3.7.2.3. Market size and forecast, by Distribution Channel
9.3.7.2.4. Market size and forecast, by End User
9.3.7.2.5. Market size and forecast, by Prescription Type
9.3.7.3. UK
9.3.7.3.1. Market size and forecast, by Type
9.3.7.3.2. Market size and forecast, by Base
9.3.7.3.3. Market size and forecast, by Distribution Channel
9.3.7.3.4. Market size and forecast, by End User
9.3.7.3.5. Market size and forecast, by Prescription Type
9.3.7.4. Italy
9.3.7.4.1. Market size and forecast, by Type
9.3.7.4.2. Market size and forecast, by Base
9.3.7.4.3. Market size and forecast, by Distribution Channel
9.3.7.4.4. Market size and forecast, by End User
9.3.7.4.5. Market size and forecast, by Prescription Type
9.3.7.5. Spain
9.3.7.5.1. Market size and forecast, by Type
9.3.7.5.2. Market size and forecast, by Base
9.3.7.5.3. Market size and forecast, by Distribution Channel
9.3.7.5.4. Market size and forecast, by End User
9.3.7.5.5. Market size and forecast, by Prescription Type
9.3.7.6. Rest of Europe
9.3.7.6.1. Market size and forecast, by Type
9.3.7.6.2. Market size and forecast, by Base
9.3.7.6.3. Market size and forecast, by Distribution Channel
9.3.7.6.4. Market size and forecast, by End User
9.3.7.6.5. Market size and forecast, by Prescription Type
9.4. Asia-Pacific
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Market size and forecast, by Type
9.4.3. Market size and forecast, by Base
9.4.4. Market size and forecast, by Distribution Channel
9.4.5. Market size and forecast, by End User
9.4.6. Market size and forecast, by Prescription Type
9.4.7. Market size and forecast, by country
9.4.7.1. Japan
9.4.7.1.1. Market size and forecast, by Type
9.4.7.1.2. Market size and forecast, by Base
9.4.7.1.3. Market size and forecast, by Distribution Channel
9.4.7.1.4. Market size and forecast, by End User
9.4.7.1.5. Market size and forecast, by Prescription Type
9.4.7.2. China
9.4.7.2.1. Market size and forecast, by Type
9.4.7.2.2. Market size and forecast, by Base
9.4.7.2.3. Market size and forecast, by Distribution Channel
9.4.7.2.4. Market size and forecast, by End User
9.4.7.2.5. Market size and forecast, by Prescription Type
9.4.7.3. Australia
9.4.7.3.1. Market size and forecast, by Type
9.4.7.3.2. Market size and forecast, by Base
9.4.7.3.3. Market size and forecast, by Distribution Channel
9.4.7.3.4. Market size and forecast, by End User
9.4.7.3.5. Market size and forecast, by Prescription Type
9.4.7.4. India
9.4.7.4.1. Market size and forecast, by Type
9.4.7.4.2. Market size and forecast, by Base
9.4.7.4.3. Market size and forecast, by Distribution Channel
9.4.7.4.4. Market size and forecast, by End User
9.4.7.4.5. Market size and forecast, by Prescription Type
9.4.7.5. South Korea
9.4.7.5.1. Market size and forecast, by Type
9.4.7.5.2. Market size and forecast, by Base
9.4.7.5.3. Market size and forecast, by Distribution Channel
9.4.7.5.4. Market size and forecast, by End User
9.4.7.5.5. Market size and forecast, by Prescription Type
9.4.7.6. Rest of Asia-Pacific
9.4.7.6.1. Market size and forecast, by Type
9.4.7.6.2. Market size and forecast, by Base
9.4.7.6.3. Market size and forecast, by Distribution Channel
9.4.7.6.4. Market size and forecast, by End User
9.4.7.6.5. Market size and forecast, by Prescription Type
9.5. LAMEA
9.5.1. Key market trends, growth factors and opportunities
9.5.2. Market size and forecast, by Type
9.5.3. Market size and forecast, by Base
9.5.4. Market size and forecast, by Distribution Channel
9.5.5. Market size and forecast, by End User
9.5.6. Market size and forecast, by Prescription Type
9.5.7. Market size and forecast, by country
9.5.7.1. Brazil
9.5.7.1.1. Market size and forecast, by Type
9.5.7.1.2. Market size and forecast, by Base
9.5.7.1.3. Market size and forecast, by Distribution Channel
9.5.7.1.4. Market size and forecast, by End User
9.5.7.1.5. Market size and forecast, by Prescription Type
9.5.7.2. Saudi Arabia
9.5.7.2.1. Market size and forecast, by Type
9.5.7.2.2. Market size and forecast, by Base
9.5.7.2.3. Market size and forecast, by Distribution Channel
9.5.7.2.4. Market size and forecast, by End User
9.5.7.2.5. Market size and forecast, by Prescription Type
9.5.7.3. South Africa
9.5.7.3.1. Market size and forecast, by Type
9.5.7.3.2. Market size and forecast, by Base
9.5.7.3.3. Market size and forecast, by Distribution Channel
9.5.7.3.4. Market size and forecast, by End User
9.5.7.3.5. Market size and forecast, by Prescription Type
9.5.7.4. Rest of LAMEA
9.5.7.4.1. Market size and forecast, by Type
9.5.7.4.2. Market size and forecast, by Base
9.5.7.4.3. Market size and forecast, by Distribution Channel
9.5.7.4.4. Market size and forecast, by End User
9.5.7.4.5. Market size and forecast, by Prescription Type
CHAPTER 10: COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2022
CHAPTER 11: COMPANY PROFILES
11.1. Bayer AG
11.1.1. Company overview
11.1.2. Key executives
11.1.3. Company snapshot
11.1.4. Operating business segments
11.1.5. Product portfolio
11.1.6. Business performance
11.2. Bliss GVS Pharma Ltd
11.2.1. Company overview
11.2.2. Key executives
11.2.3. Company snapshot
11.2.4. Operating business segments
11.2.5. Product portfolio
11.2.6. Business performance
11.3. Viatris Inc.
11.3.1. Company overview
11.3.2. Key executives
11.3.3. Company snapshot
11.3.4. Operating business segments
11.3.5. Product portfolio
11.3.6. Business performance
11.4. Church & Dwight Co. Inc.
11.4.1. Company overview
11.4.2. Key executives
11.4.3. Company snapshot
11.4.4. Operating business segments
11.4.5. Product portfolio
11.4.6. Business performance
11.5. Glenmark Pharmaceuticals Limited
11.5.1. Company overview
11.5.2. Key executives
11.5.3. Company snapshot
11.5.4. Operating business segments
11.5.5. Product portfolio
11.5.6. Business performance
11.6. Intas Pharmaceuticals Ltd.
11.6.1. Company overview
11.6.2. Key executives
11.6.3. Company snapshot
11.6.4. Operating business segments
11.6.5. Product portfolio
11.7. Cadila Healthcare Ltd
11.7.1. Company overview
11.7.2. Key executives
11.7.3. Company snapshot
11.7.4. Operating business segments
11.7.5. Product portfolio
11.7.6. Business performance
11.7.7. Key strategic moves and developments
11.8. Novartis AG
11.8.1. Company overview
11.8.2. Key executives
11.8.3. Company snapshot
11.8.4. Operating business segments
11.8.5. Product portfolio
11.8.6. Business performance
11.9. Pfizer Inc.
11.9.1. Company overview
11.9.2. Key executives
11.9.3. Company snapshot
11.9.4. Operating business segments
11.9.5. Product portfolio
11.9.6. Business performance
11.10. Sanofi S.A.
11.10.1. Company overview
11.10.2. Key executives
11.10.3. Company snapshot
11.10.4. Operating business segments
11.10.5. Product portfolio
11.10.6. Business performance
TABLE 01. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. PHARMACEUTICAL SUPPOSITORIES MARKET FOR RECTAL SUPPOSITORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. PHARMACEUTICAL SUPPOSITORIES MARKET FOR VAGINAL SUPPOSITORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. PHARMACEUTICAL SUPPOSITORIES MARKET FOR URETHRAL SUPPOSITORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 06. PHARMACEUTICAL SUPPOSITORIES MARKET FOR FATTY BASES, BY REGION, 2022-2032 ($MILLION)
TABLE 07. PHARMACEUTICAL SUPPOSITORIES MARKET FOR WATER MISCIBLE BASE, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL WATER MISCIBLE BASE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 09. PHARMACEUTICAL SUPPOSITORIES MARKET FOR EMULSIFYING BASES, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL EMULSIFYING BASES PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 12. PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
TABLE 13. PHARMACEUTICAL SUPPOSITORIES MARKET FOR RETAIL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
TABLE 14. PHARMACEUTICAL SUPPOSITORIES MARKET FOR ONLINE SALES, BY REGION, 2022-2032 ($MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
TABLE 17. PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOME CARE, BY REGION, 2022-2032 ($MILLION)
TABLE 18. PHARMACEUTICAL SUPPOSITORIES MARKET FOR NURSING HOME, BY REGION, 2022-2032 ($MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 20. PHARMACEUTICAL SUPPOSITORIES MARKET FOR OTC, BY REGION, 2022-2032 ($MILLION)
TABLE 21. PHARMACEUTICAL SUPPOSITORIES MARKET FOR PRESCRIBED SUPPOSITORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 22. PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 24. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 26. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 28. NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 29. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 30. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 31. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 32. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 34. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 35. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 36. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 37. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 38. CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 39. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 41. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 42. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 43. MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 44. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 45. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 46. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 47. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 49. EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 50. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 51. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 52. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 53. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 55. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 56. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 57. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 58. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 60. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 61. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 62. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 63. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 65. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 66. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 67. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 68. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 69. ITALY PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 70. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 71. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 72. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 73. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 74. SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 75. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 76. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 77. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 78. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 79. REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 80. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 81. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 82. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 83. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 84. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 85. ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 86. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 87. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 88. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 89. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 90. JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 91. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 92. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 93. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 94. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 95. CHINA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 96. AUSTRALIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 97. AUSTRALIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 98. AUSTRALIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 99. AUSTRALIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 100. AUSTRALIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 101. INDIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 102. INDIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 103. INDIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 104. INDIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 105. INDIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 106. SOUTH KOREA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 107. SOUTH KOREA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 108. SOUTH KOREA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 109. SOUTH KOREA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 110. SOUTH KOREA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 111. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 112. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 113. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 114. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 115. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 116. LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 117. LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 118. LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 119. LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 120. LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 121. LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 122. BRAZIL PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 123. BRAZIL PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 124. BRAZIL PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 125. BRAZIL PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 126. BRAZIL PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 127. SAUDI ARABIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 128. SAUDI ARABIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 129. SAUDI ARABIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 130. SAUDI ARABIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 131. SAUDI ARABIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 132. SOUTH AFRICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 133. SOUTH AFRICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 134. SOUTH AFRICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 135. SOUTH AFRICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 136. SOUTH AFRICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 137. REST OF LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 138. REST OF LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2022-2032 ($MILLION)
TABLE 139. REST OF LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 140. REST OF LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 141. REST OF LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE, 2022-2032 ($MILLION)
TABLE 142. BAYER AG: KEY EXECUTIVES
TABLE 143. BAYER AG: COMPANY SNAPSHOT
TABLE 144. BAYER AG: PRODUCT SEGMENTS
TABLE 145. BAYER AG: PRODUCT PORTFOLIO
TABLE 146. BLISS GVS PHARMA LTD: KEY EXECUTIVES
TABLE 147. BLISS GVS PHARMA LTD: COMPANY SNAPSHOT
TABLE 148. BLISS GVS PHARMA LTD: PRODUCT SEGMENTS
TABLE 149. BLISS GVS PHARMA LTD: PRODUCT PORTFOLIO
TABLE 150. VIATRIS INC.: KEY EXECUTIVES
TABLE 151. VIATRIS INC.: COMPANY SNAPSHOT
TABLE 152. VIATRIS INC.: PRODUCT SEGMENTS
TABLE 153. VIATRIS INC.: PRODUCT PORTFOLIO
TABLE 154. CHURCH & DWIGHT CO. INC.: KEY EXECUTIVES
TABLE 155. CHURCH & DWIGHT CO. INC.: COMPANY SNAPSHOT
TABLE 156. CHURCH & DWIGHT CO. INC.: PRODUCT SEGMENTS
TABLE 157. CHURCH & DWIGHT CO. INC.: PRODUCT PORTFOLIO
TABLE 158. GLENMARK PHARMACEUTICALS LIMITED: KEY EXECUTIVES
TABLE 159. GLENMARK PHARMACEUTICALS LIMITED: COMPANY SNAPSHOT
TABLE 160. GLENMARK PHARMACEUTICALS LIMITED: PRODUCT SEGMENTS
TABLE 161. GLENMARK PHARMACEUTICALS LIMITED: PRODUCT PORTFOLIO
TABLE 162. INTAS PHARMACEUTICALS LTD.: KEY EXECUTIVES
TABLE 163. INTAS PHARMACEUTICALS LTD.: COMPANY SNAPSHOT
TABLE 164. INTAS PHARMACEUTICALS LTD.: PRODUCT SEGMENTS
TABLE 165. INTAS PHARMACEUTICALS LTD.: PRODUCT PORTFOLIO
TABLE 166. CADILA HEALTHCARE LTD: KEY EXECUTIVES
TABLE 167. CADILA HEALTHCARE LTD: COMPANY SNAPSHOT
TABLE 168. CADILA HEALTHCARE LTD: PRODUCT SEGMENTS
TABLE 169. CADILA HEALTHCARE LTD: PRODUCT PORTFOLIO
TABLE 170. CADILA HEALTHCARE LTD: KEY STRATERGIES
TABLE 171. NOVARTIS AG: KEY EXECUTIVES
TABLE 172. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 173. NOVARTIS AG: PRODUCT SEGMENTS
TABLE 174. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 175. PFIZER INC.: KEY EXECUTIVES
TABLE 176. PFIZER INC.: COMPANY SNAPSHOT
TABLE 177. PFIZER INC.: PRODUCT SEGMENTS
TABLE 178. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 179. SANOFI S.A.: KEY EXECUTIVES
TABLE 180. SANOFI S.A.: COMPANY SNAPSHOT
TABLE 181. SANOFI S.A.: PRODUCT SEGMENTS
TABLE 182. SANOFI S.A.: PRODUCT PORTFOLIO
